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ABSTRACT
Purpose: To investigate the feasibility of using processed
human amniotic membrane (HAM) to support the
attachment and proliferation of chondrocytes in vitro which
in turn can be utilised as a cell delivery vehicle in tissue
engineering applications. Methods: Fresh HAM obtained
from patients undergoing routine elective caesarean sections
was harvested, processed and dried using either freeze drying
(FD) or air drying (AD) methods prior to sterilisation by
gamma irradiation. Isolated, processed and characterised
rabbit autologous chondrocytes were seeded on processed
HAM and cultured for up to three weeks. Cell attachment
and proliferation were examined qualitatively using inverted
brightfield microscopy. Results: Processed HAM appeared
to allow cell attachment when implanted with chondrocytes.
Although cells seeded on AD and FD HAM did not appear to
attach as strongly as those seeded on glycerol preserved
intact human amniotic membrane, these cells to be
proliferated in cell culture conditions.  Conclusion:
Preliminary results show that processed HAM promotes
chondrocyte attachment and proliferation.
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INTRODUCTION
Articular cartilage is a highly organised connective tissue
located on surfaces of diarthroidal joints designed to absorb
and distribute high amounts of mechanical loads 1. Injury to
articular cartilage is therapeutically irreversible due to the
largely avascular nature of this tissue and the self-limited
regenerative ability of the cartilage cells 2, 3. Physically
mediated cartilage degeneration is often the result of both
chronic and acute insults to the cartilage surface, leading to
osteoarthritis, which is currently a major health problem
worldwide 4, 5.   It is well known that osteoarthritis of the knee
joints impedes mobility and negatively impacts upon quality
of life resulting in a major financial healthcare burden 6, 7.  In
trying to reduce the progression of the disease in the
relatively young patient with established cartilage damage, a
number of surgical options have been advocated to aid in
early tissue repair. These include microfracture, athroscopic
lavage, abrasion, and sub-chondral drilling 8, 9.  However,
these procedures have been reported to have inconsistent
short to midterm clinical outcomes, with most clinicians
reporting that the majority of their patients did not have
substantial improvements 10-14. 
The emergence of cell-based therapies offers the prospect of
a more effective therapeutic treatment which involves the
regeneration of injured articular cartilage. One of the most
successful methods is the autologous chondrocyte
implantation (ACI) 15 technique which has gained popularity
over conventional methods over the past decade 16.   ACI,
which is based on a tissue engineering concept, has enabled
the regeneration of hyaline-like cartilage upon it successful
transplantation in cartilage defects as compared to the
production of fibrocartilage tissue in the repaired sites using
other regular techniques; which, if remain uncorrected, will
result in detrimental outcomes to the joint. However, the
benefits of ACI are offset by a number of limitations which
include incomplete regeneration of the defective cartilage,
periosteal hyperthrophy, the limited availability of autologous
chondrocyte, and the reduced proliferative activity of cells
obtained from the more elderly patients 17-19.   These
limitations have driven the need for a cell delivery vehicle
which combines both cell and scaffolding materials for
transplanted chondrocytes to proliferate and retain their
native phenotypic characteristics within the defect sites. This
in turn will allow effective repair to take place within these
sites and  produce repair tissue which mimics the surrounding
native cartilage. Cell scaffolding provides at least two
functions in cell transplant therapies. Its designed structure
not only assists in the integration of transplanted cells to the
host tissue; but it also supports cell attachment and enhances
cell proliferation. Their role as one of the key components in
tissue engineering is reflected by an ever increasing number
of published works over the past decade 20-23. To ensure that
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effective repair and regeneration of injured tissues and
organs can take place, seeding of cells onto the three-
dimensional scaffold is important as cell-matrix interaction
that occurs in these constructs helps to provide better cell
expressions 24-27.  However, one of the major limitations of
clinical application of scaffolding is the availability of a
material which is both biocompatible and biodegradable. 
In an attempt to discover a suitable material which has both
of these properties, human amniotic membranes (HAM)
offered potential owing to its many desirable properties.
HAM is inert, biocompatible, biodegradable, and more
importantly has been used successfully in the past for tissue
transplantation. Since initial surgical use as a skin graft
material 28, HAM has proven to be an excellent tissue
transplantation material with clinical applications being
reported with good to excellent outcomes for a variety of
diseases 29, 30. However, the use of HAM in tissue engineering
has not been widely reported 31, 32. This study was therefore
conducted to investigate the feasibility of processed HAM as
a cell carrier for cultivation of chondrocytes.
MATERIALS AND METHODS
Procurement and processing of human amniotic
membranes (HAM)
Amniotic membranes (n=3) from placentas were collected
and processed in accordance to the approval from the
Medical Ethics Committee, University of Malaya. Human
placentas were obtained by the operating obstetricians from
elective Caesarean-sectioned mothers who were seronegative
for hepatitis B and C, syphilis, and human
immunodeficiency virus. Informed consent was obtained
from all donors. Following the delivery of the placenta, the
amnion membrane was carefully peeled off from the
placental mass and washed with running water. Blood clots
present on the surface were carefully removed. The amniotic
membrane was then placed in a bottle containing sterile
normal saline and stored at 4°C before further processing.
The following day, the amniotic membrane was transferred
into another sterile bottle containing sterile distilled water.
The amnion was then washed for 10 minutes in a shaker
before being transferred into another bottle containing 0.05%
(v/v) sodium hypochlorite and slowly agitated for another 10
minutes. Three subsequent treatments consisting of washing
with normal saline and agitation for 20 minutes were
performed. Each donor membrane was then cut in half and
processed by 2 different methods: air dried (AD) or freeze
dried (FD). For the AD group, the cleaned amniotic
membrane was spread and dried under laminar flow hood
overnight. For the FD group, the stretched amniotic
membrane was placed in plastic bags in the freeze dryer for
6 hours. The AD and FD membranes were then trimmed to
size (2cm x 2cm) before being packed into vacuum sealed
packages. These processes were all performed within the
laminar flow hood environment to reduce possible
contamination. The packed clean amniotic membranes were
then delivered for sterilisation using gamma rays (Cobalt 60)
at 25 kGy for how long.  Following irradiation, the packed
HAMs were kept in a dry cabinet away from direct sunlight
until used for further analysis. The sterility and efficacy of
processing amnion has been described previously 33.
Characterisation of HAM before cell seeding
To investigate the structure of the processed HAM after the
air drying and freeze drying techniques, the processed HAM
was subjected to histological examination. Both FD and AD
HAM were fixed by immersing HAM in 10% buffered
formalin solution overnight and subjecting to serial
dehydration in ethanol 70% twice, 95% twice, 100% thrice,
toluene thrice, and wax thrice for one hour each. The
processed HAM was embedded in paraffin, and then
sectioned into 5μm thicknesses using a microtome.
Hematoxylin and Eosin staining was performed to
differentiate the two main layers of the processed HAM,
namely, epithelial and basement layers. For experimental
control, we used commercially available glycerol preserved
intact human amniotic membranes (GPHAM).  The GPHAM
was also fixed, embedded and subjected to histological
examination as described above in order to perform similar
characterisation process. 
Isolation and culture of rabbit autologous chondrocytes
(RAC)
Regulations on animal experimentation were strictly adhered
to throughout the study as determined by the University of
Malaya animal ethics approval. New Zealand white rabbits
(n=3) aged between 3 to 4 months and weighing
approximately 2.5 kg were used for this study.  The rabbits
were sacrificed by an overdose intravenous injection of
Pentobarbital. Articular cartilage from the shoulders, hips
and knees was harvested under sterile conditions as
described previously 34.  Once chondrocyte confluence was
achieved, cells were trypsinised and suspended for further
analysis in the study. Cell number and viability were
determined using the Trypan blue dye exclusion method. 
Characterisation of cultured RAC
To ensure that the cells isolated consisted of homogeneous
populations of autologous chondrocytes, cell
characterisations were performed. Cell detachment from
culture vessels at passages 1 (P1) and 2 (P2) was followed by
seeding at 10, 000 cells per chamber in the four well chamber
slides.  After 3-4 days, the slides underwent Hematoxylin and
Eosin (H&E) staining for morphological examination and
Safranin-O/fast green staining to determine matrix
proteoglycan depositions.  Immunocytochemistry staining
was performed using a Dako immunostaining kit
(DakoCytomation, USA) to detect the presence of collagen
type II. Slides were fixed in methanol for 15 minutes before
being rinsed with Tris-buffered saline (TBS) and further
treated with 0.03% hydrogen peroxide containing sodium
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azide. These slides were then incubated with primary
antibody against type II collagen (mice antibody) for 30
minutes before being further incubated with peroxidase
labelled polymer conjugated to goat anti-mouse
immunoglobulins for 30 minutes. The resulting slides were
then stained with liquid diaminobenzidine (DAB kit,
DakoCytomation, USA) for visualisation and observed using
the light microscope to verify the presence of type II
collagen.
Seeding of RAC on HAM substrates
The primary culture of RAC was routinely maintained,
expanded, and passaged. The second passage (P2) of the cells
was subsequently detached and seeded onto the three
different substrates. Cell counts were performed prior to
seeding to ensure consistency of seeding density. The cells
were in culture for about three weeks and subject to
microscopic observation. Samples of the membranes (n=3)
of processed HAM (AD or FD) and GPHAM approximately
4cm2 were placed individually into a small sterile 35mm ultra
low attachment culture dish (Corning Inc., Corning, NY).  In
each of the culture dishes, an autoclavable stainless steel ring
was placed on top of the amniotic membrane to prevent
curling up of the membrane upon addition of culture
medium. The amniotic membrane was spread uniformly,
basement membrane-side up, onto the bottom of the dish
with sterile forceps before cells were seeded.  RAC at
passage 2 (P2) were seeded at 4 x 105 cells per membrane.
Cultures were cultivated in growth medium at 37°C in a
humidified incubator with 5% carbon dioxide supply with
medium changed three times a week. Examination using
inverted brightfield microscopy of the cultures was carried
out throughout the three week culture.
Characterisation of HAM after cell seeding
To observe the attachment patterns of the seeded
chondrocytes on the different HAM substrates, the samples
were subjected to histology staining after 21 days. The
resultant slides were then observed using light microscopy
and photographed using Infinity 2.0 camera and software. 
RESULTS
Characterisation of RAC 
Primary culture of RAC was established using the enzymatic
digestion method, forming a monolayer which attained
confluence at day 10. Using inverted brightfield microscopy,
once confluence is reached, these cells appeared flattened
and almost spherical in shape. Staining with H&E
demonstrated multipolar and bipolar morphology of
chondrocytes with rounded bluish-black nuclei and pink
cytoplasm in the monolayer arrangement (Figs 1a, b).
Immunohistochemistry of monolayer chondrocytes cultured
on chamber slides with Safranin-O/fast green staining
showed positive for the presence of proteoglycans in the
extracellular matrix (Fig 1c). The presence of proteoglycans
(stained red) was most evident in the territorial and
interterritorial areas of the cells (Fig. 1d).
Immunocytochemistry of the chondrocytes in monolayer on
chamber slides was positive for type II collagen in the
pericellular and intracellular regions (Figs 1e, f). 
Morphologic characterisation of the HAM substrates
before cell seeding
Gross appearance did not reveal any significant
morphological differences between the unprocessed
(control) and processed HAM.  HAM appeared to be light,
transparent, thin, easy to handle and curvy upon hydration.
Examination of the GPHAM using light microscopy revealed
a continuous strata layer of epithelial cells with cuboidal and
polygonal cells (Fig. 2a). The nuclei of both types appeared
large, dense, ovoid and centrally located in the cytoplasm.
The underlying layers were evidently intact to the extent of
the epithelial layer being observed to include a smooth layer
of fibrous collagen stroma. In contrast, H&E stained slides
from the FD group revealed an indistinct layer of epithelium
and basement membrane due to the physical alterations upon
freeze drying treatment (Fig. 2b). The epithelial layers had
collapsed and become indistinct from the underlying
membranes. However, the network of collagen fibrils was
still clearly present and remained intact to the membranes. In
the AD group, the H&E staining revealed tight adherence
and alignment of the epithelial cells to the surface of the
basement membrane (Fig. 2c). 
Observation of cells seeded on HAM substrates
Chondrocytes appeared in single and aggregate following 30
minutes of seeding on all substrates (Figs 3a, d, g). The
seeded chondrocytes appeared rounded and refractive
indicating that the cells were viable. After one hour, the
majority of single chondrocytes remained in suspension
whilst smaller aggregated chondrocytes had attached to the
substrates (Fig. 3d).  Attachment of chondrocytes became
stable within the first day following seeding and occurred at
the same rate on all other substrates (replicates).
Chondrocytes which had initially been in aggregate remained
attached and showed signs of proliferation. By the third day
of culture, protrusion and outgrowth of flattened cells from
the peripheral regions of cell colonies demonstrated clear
proliferation on all substrates (Figs 3b, e, and h). On
ADHAM and FDHAM substrates, upon changing of culture
medium, some of the attaching cells appeared to have
detached from the surfaces possibly due to accidental
mechanical agitation or fluid shear forces. In contrast, almost
all of the cells which were attached on GPHAM from Day-1
appeared to have survived, underwent morphologic changes,
and remained attached to the membrane until day 21. The
chondrocytes were fairly uniform in size and in close contact
with one another. Rather than forming a monolayer, the
chondrocytes infiltrated into the extracellular matrix of the
basement membrane forming a clump-like structure  as
shown in the paraffin sections (Figs 4a and b). In the
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Fig. 1 Characterisation of RAC using morphological and immunohistochemical
staining. (a, b) hematoxylin and eosin , (c, d) Safranin-O/Fast green,  (e, f)
Type II collagen. (X100 and X400 magnification).
Fig. 3 Inverted brightfield microscopy images of the RAC
seeded on different substrates. Cell proliferation on the
ADHAM and FDHAM was indicated by the outgrowth of
the cells (thin arrows). Cell colonies attached to the
GPHAM (thick arrow) (X200 magnification).
Fig. 4 Cross sections of the HAM seeded with cells stained with
hematoxylin and eosin.  (a,c,e) X100 magnification.
(b,d,f) X400 magnification.
ADHAM section, chondrocytes attached along the basement
membrane but not in close contact with one another (Figs 4c
and d). Comparatively, chondrocytes seeded on FDHAM
appears to have attached less firmly to the membrane and
were removed during the tissue processing (Figs 4e and f).
This suggests that although both ADHAM and FDHAM
appear to promote cell proliferation, the amount differs with
the different preparations.
Fig. 2 Cross-sections of the HAM, stained with
hematoxylin and eosin. (a) GPHAM, (b)
FDHAM, (c) ADHAM.  (E- Epithelium and
B-basement membrane) (X400
magnification).
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DISCUSSION
The choice of a cell carrier is an important aspect of tissue
engineering as it can greatly influence cell attachment,
migration, differentiation, mass transport, mechanical
integrity of tissue constructs and their subsequent integration
in vivo 35, 36.   Ideally, a scaffold used as a cell delivery vehicle
should be reproducible, of three-dimensional form, have a
high porosity so that cell distribution during cell seeding can
be uniform, be able to minimise diffusional constraints
during in vitro cultivation, and be able to provide controlled
biodegradation for long-term gradual creeping substitution 24, 25.
The success of tissue engineered constructs for cartilage
repair and regeneration depends on the biocompability and
biodegradability of the appropriate scaffold materials.
A wide range of scaffolds, either synthetic or natural
polymers, has been developed and investigated for the
cartilage repair and regeneration. The most widely used
synthetic scaffold materials are FDA-approved polyglycolic
acid (PGA) and poly L-lactic acid (PLLA) 37, 38.  Both PGA
and PLLA are biodegradable polymers often used in
orthopaedics. Conversely, naturally derived polymers such as
collagen, alginate gels and injectable hydrogels have also
been extensively studied 39-43.  Nevertheless, both types of
scaffold material are financially prohibitive, and require
extensive processing before they can be fully utilised. The
unique characteristics of HAM such as availability, cost-
effectiveness, and present of various growth factors make it
a valuable biological matrix with the potential of delivering
tissue engineering solutions at a lower cost and with fewer
processing requirements 30, 31, 44, 45.
Among the five layers, the basement membrane of the
amniotic membrane is of great interest in our study as it is a
membrane made of collagen fibers, fibronectin and laminin 46.
The basement membrane is a thin layer composed of
reticular fibers adhered to the base of the amniotic
epithelium; the adherence of the basement membrane to the
other layers is firm and separation of the layers is not easily
achieved 47.  However, in our study, following air or freeze
drying and later exposed to gamma irradiation, the basement
membrane was separated from the underlying layers but
remained adherent to the epithelial layer with an intact
collagen structure (Figs 2a, b, and c). The basement
membranes were used for seeding throughout the study.  In
addition, to minimise the manipulation of HAM, we did not
denude the epithelial cells from the basement membrane. It
is noted that denudation of the epithelial layer was performed
in previous studies, e.g. Nakamura et al. 44. which
demonstrated cultivation and transplantation of non-ocular
surface origin cells (oral epithelial cells) on the denuded
HAM carrier. Denuded human amniotic membrane that did
not possess cells or residual nucleic acid was thought to be
important as it could minimise the cell-mediated immune
response following clinical implantation 30, 48.   Limbal cells
grown on denuded amniotic membrane appeared well
stratified and differentiated, and was preferred to the results
attained from monolayer cells grown on the intact amniotic
membrane 49.  Denudation of HAM involves the treatment of
the intact HAM with EDTA at 37 °C and the scraping out of
the epithelial cells under a microscope.  However, the usage
of denuded or intact HAM is largely dependent on the type
of cell to be implanted and, more importantly, its final
clinical application. In the present study, the denudation of
the epithelium cells from the basement membrane was
irrelevant as the aim was to seed the chondrocytes on the
basement membrane and not on the epithelial layer. 
All substrates (GPHAM, ADHAM and FDHAM) appeared
to have supported the attachment and proliferation of cells on
its surfaces. The attachment of cells to scaffolds was largely
affected by the components of the scaffold’s extracellular
matrix components and the length of time the cells were left
to rest on the surfaces. This was due to the presence of the
extracellular matrix (ECM) components such as collagen,
laminin, fibronectin, and vitronectin within the basement
membrane of the intact HAM providing a favourable
environment for cell attachment 32.   In our results, although
the attachment rate was not quantified, we observed that cell
aggregates had a higher attachment ability compared to
single cells, an effect which might be explained by the
secretion of proteoglycans and type II collagen stimulated by
cell-to-cell interaction in these aggregates. These
extracellular matrix proteins may help the cell aggregates to
have a better attachment on the basement membrane, which
is also predominantly high in collagen. These chondrocyte-
matrix interactions may enhance the secretion of
extracellular matrix components and other trophic factors
from implanted chondrocytes. This, in turn, will further
assist in cell attachment, proliferation and maintenance in
cell culture systems. However, the detachment of some of the
cells from the ADHAM and FDHAM cultures after one week
of culture demonstrated unstable attachment of extracellular
matrix components of the cell-matrix interaction. The weak
attachment together with the shear forces during medium
changes accounts for cell loss on these substrates. In
contrast, cells seeded with GPHAM tended to do better with
cells attaching firmly up to 3 weeks in cell culture
environment, possibly due to secretion of certain growth
factors in the preserved amnion membranes compared to the
processed membranes.  However this may be due to the fact
that the number of cells was fewer on the AD and FD HAM
due to cell detachments during the change of culture
medium. 
Despite the relatively inferior attachment and proliferation of
cells on the processed HAM (ADHAM and FDHAM) as
compared to GPHAM in prolonged cell culture environment,
the strong and early attachment of cells on these substrates
and the successful maintenance of cultured cell on GPHAM
substrates for prolonged periods indicate promising clinical
potential for HAM in general to be used as a cell carrier.
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Moreover, a more recent study has demonstrated the ability
of denuded HAM, especially the stromal side, to support
chondrocyte proliferation and maintenance of phenotype in
vitro and regeneration of hyaline cartilage in vivo 50.
However, in our study, the results of the ADHAM, FDHAM
and GPHAM could not be compared because the structure of
the processed HAM was different from the denuded HAM.
Although, in this preliminary report, HAM appears to
demonstrate positive results which supports our hypothesis
that HAM may be useful as a cell carrier for tissue
engineering application, further assessment is required
before any conclusive use for practical application can be
undertaken.  Further characterisation of the three different
substrates in terms of their biochemical compositions, the
specific collagen fibres which account for the different
attachment patterns, and the distribution and proliferation of
the chondrocytes will enable a more concrete assessment of
the properties of processed HAM. This would also provide
the necessary knowledge on how to improve the properties of
HAM in order to promote enhanced cell proliferation and
expression.  Further biomechanical analysis to measure the
strength of the membranes, scanning electron microscopy to
visualise the infiltration and proliferation of the cells, and in
vivo animal studies are also needed to fully assess the
suitability of these substrates in cartilage regeneration.
CONCLUSION
These preliminary results show that AD and FD HAM may
support a degree of chondrocyte proliferation.  However, the
processing methods  described here do not appear to have
provided better cell attachments when compared to GPHAM,
thus warranting the need to further improve current
protocols. In general, HAM appears to provide a suitable
environment for cell attachment and proliferation. In light of
its successful history in tissue transplantations, HAM may
become the much needed biological cell carrier for tissue
engineering purposes.
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